Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000996-26Phase 4Completed
Phase 4, open-label trial of albumin (human) in burn injury (2 arms), sponsored by Region Östergötland. Primary endpoint: Plasma volume expansion at 4 hours. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000996-26.